Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07573813
Novel SaCoVLM™ Video Laryngeal Mask Airway as an Intubation Conduit in Morbidly Obese Bariatric SurgeryYongtao SunCompleted
NCT07573813Completed
—
Novel SaCoVLM™ Video Laryngeal Mask Airway as an Intubation Conduit in Morbidly...Yongtao Sun
NCT07573943
ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus InfectionFirst Affiliated Hospital of Chongqing Medical UniversityRecruitingPhase 4
NCT07573943Recruiting
Phase 4
ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chron...First Affiliated Hospital...
NCT07573085
Internet-delivered Emotion Regulation Individual Therapy or Adolescents (IERITA) With Self-injury Within Child and Adolescent Mental Health ServicesKarolinska InstitutetNot Yet RecruitingNot Applicable
NCT07573085Not Yet Recruiting
Not Applicable
Internet-delivered Emotion Regulation Individual Therapy or Adolescents (IERITA)...Karolinska Institutet
NCT07572110
Project Independence: Randomized Controlled TrialUniversity of MiamiNot Yet RecruitingNot Applicable
NCT07572110Not Yet Recruiting
Not Applicable
Project Independence: Randomized Controlled TrialUniversity of Miami
NCT07572214
Markerless Motion Capture for 3D Clinical Gait Analysis (IMAGine)Alder Hey Children's NHS Foundation TrustCompleted
NCT07572214Completed
—
Markerless Motion Capture for 3D Clinical Gait Analysis (IMAGine)Alder Hey Children's NHS...
NCT07572006
A Study of JNJ-95804306 for Relapsed or Refractory Hematological MalignanciesJanssen Research & Development, LLCNot Yet RecruitingPhase 1
NCT07572006Not Yet Recruiting
Phase 1
A Study of JNJ-95804306 for Relapsed or Refractory Hematological MalignanciesJanssen Research & Develo...
NCT07573215
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic AdenocarcinomaRevolution Medicines, Inc.Unknown
NCT07573215Unknown
—
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metast...Revolution Medicines, Inc...
NCT07573618
Acute or Subacute Iliofemoral Vein Thrombosis: Aspiration for Flow Restoration Versus Standard AnticoagulationWeiwei WuNot Yet RecruitingNot Applicable
NCT07573618Not Yet Recruiting
Not Applicable
Acute or Subacute Iliofemoral Vein Thrombosis: Aspiration for Flow Restoration V...Weiwei Wu
NCT07574242
Effect of vitk2 on Atopic Dermatitis Pediatrics PatientsOctober 6 UniversityCompletedNot Applicable
NCT07574242Completed
Not Applicable
Effect of vitk2 on Atopic Dermatitis Pediatrics PatientsOctober 6 University
NCT07572851
Functional Changes and Fall Risk in Older Adults Participating in a Frailty ProgramUniversity of VigoEnrolling By Invitation
NCT07572851Enrolling By Invitation
—
Functional Changes and Fall Risk in Older Adults Participating in a Frailty Prog...University of Vigo
NCT07572253
A Study of Using CARTO SOUND™ FAM to Guide Pulsed Field Ablation for Atrial FibrillationCentral China Fuwai Hospital of Zhengzhou UniversityNot Yet RecruitingNot Applicable
NCT07572253Not Yet Recruiting
Not Applicable
A Study of Using CARTO SOUND™ FAM to Guide Pulsed Field Ablation for Atrial Fibr...Central China Fuwai Hospi...
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07573358
Validation of Artificial Intelligence-Based Facial Paralysis Assessment in Patients With Bell's PalsyCairo UniversityNot Yet Recruiting
NCT07573358Not Yet Recruiting
—
Validation of Artificial Intelligence-Based Facial Paralysis Assessment in Patie...Cairo University
NCT07574281
Effectiveness and Implementation of the DINKNESH Digital Palliative Care Tool in EthiopiaAddis Ababa UniversityNot Yet RecruitingNot Applicable
NCT07574281Not Yet Recruiting
Not Applicable
Effectiveness and Implementation of the DINKNESH Digital Palliative Care Tool in...Addis Ababa University
Result Breakdown
Not yet recruiting11 (55%)
Completed4 (20%)
Recruiting3 (15%)
Unknown1 (5%)
Enrolling by invitation1 (5%)
not_applicable10 (50%)
Not Specified8 (40%)
Phase 41 (5%)
Phase 11 (5%)